New insulin biosimilar faces off against market leader in early trial
Disease control
Completed
This completed Phase 1 trial tested whether a new biosimilar insulin called Insulex® R works similarly to the standard Humulin® R. Forty healthy adults received a single injection of each insulin in a crossover design. Researchers measured how the body absorbed the insulin and ho…
Phase: PHASE1 • Sponsor: Laboratorios Pisa S.A. de C.V. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC